0.0001
price down icon50.00%   -0.0001
 
loading

REGEN BIOPHARMA INC Stock (RGBP) Forecast

The REGEN BIOPHARMA INC (RGBP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.00686, representing a +6,759% increase from the current price of $0.0001. The highest analyst price target is $0.0136, and the lowest is $0.000131.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RGBP Price Target
Average 0.00686 (+6,759% Upside)
loading

Is REGEN BIOPHARMA INC (RGBP) A Buy Now?

Oscillators
Name Value Action
RSI(14) 48.75 Neutral
STOCH(9,6) 58.63 Neutral
STOCHRSI(14) 44.59 Neutral
MACD(12,26) 0.000011 Buy
ADX(14) 15.95 Neutral
William %R -50.25 Neutral
CCI(14) -33.96 Neutral
Buy: 1 Sell: 0 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.00013
Sell
0.000128
Sell
MA20
0.000108
Sell
0.000116
Sell
MA50
0.000108
Sell
0.000125
Sell
MA100
0.000137
Sell
0.000344
Sell
MA200
0.000782
Sell
0.00149
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, RGBP could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on RGBP, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 48.75 indicates that RGBP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 58.63 indicates that RGBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.59 indicates that RGBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 15.95 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -33.96 indicates that RGBP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term RGBP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about REGEN BIOPHARMA INC financial reports and earnings history, REGEN BIOPHARMA INC (RGBP) stock could reach $0.00629 by 2030, $0.0652 by 2040 and $0.0902 by 2050. See the projected annual prices until 2050 of the REGEN BIOPHARMA INC stock below:

  • REGEN BIOPHARMA INC (RGBP) is expected to reach an average price of $0.00716 in 2035, with a high prediction of $0.00969 and a low estimate of $0.00716. This indicates an $7,062% rise from the last recorded price of $0.0001.
  • REGEN BIOPHARMA INC (RGBP) stock is projected to chart a bullish course in 2040, with an average price target of $0.0669, representing an $66,800% surge from its current level. The forecast ranges from a conservative $0.00306 to a sky-high $0.0652.
  • Our analysts predict REGEN BIOPHARMA INC (RGBP) to jump 79,400% by 2045, soaring from $0.0801 to an average price of $0.0795, potentially reaching $0.0807. While $0.0801 is the low estimate, the potential upside is significant.
  • REGEN BIOPHARMA INC (RGBP) stock is expected to climb by 2050, reaching an average of $0.0852, a $85,149% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.0902 and $0.0861, respectively, highlighting the market's uncertainty.

REGEN BIOPHARMA INC Stock (RGBP) Year by Year Forecast

REGEN BIOPHARMA INC Stock (RGBP) Price Forecast for 2026

The predicted value for REGEN BIOPHARMA INC (RGBP) in 2026 is set at an average of $0.00679. Estimates vary from a peak of $0.0136 to a trough of $0.000001, indicating an +6,694% surge from the present price of $0.0001.
Month Average Low High Change from today's price
November, 2026 $0.000963 $0.000131 $0.0136 +862.51%
December, 2026 $0.000338 $0.000644 $0.00256 +237.52%

REGEN BIOPHARMA INC Stock (RGBP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for REGEN BIOPHARMA INC (RGBP) is $0.00143, with a high forecast of $0.00268 and a low forecast of $0.000187. This indicates an +1,334% increase from the last price of $0.0001.
Month Average Low High Change from today's price
January, 2027 $0.000013 $0.000569 $0.00193 -87.48%
February, 2027 $0.00141 $0.0009 $0.00109 +1,312%
March, 2027 $0.00284 $0.00172 $0.00214 +2,744%
April, 2027 $0.00297 $0.00285 $0.00267 +2,869%
May, 2027 $0.0024 $0.0026 $0.00268 +2,300%
June, 2027 $0.00222 $0.00242 $0.00242 +2,125%
July, 2027 $0.00205 $0.00214 $0.00213 +1,950%
August, 2027 $0.00178 $0.00178 $0.00196 +1,681%
September, 2027 $0.00131 $0.0015 $0.00159 +1,206%
October, 2027 $0.00113 $0.00113 $0.00121 +1,030%
November, 2027 $0.000562 $0.000656 $0.000837 +462.41%
December, 2027 $0.000087 $0.000187 $0.000419 -12.60%

REGEN BIOPHARMA INC Stock (RGBP) Price Forecast for 2028

In 2028, REGEN BIOPHARMA INC (RGBP) is projected to reach an average price of $0.00511, with a high projection of $0.00768 and a low estimate of $0.00254. This indicates an +5,006% rise from the last price of $0.0001.
Month Average Low High Change from today's price
January, 2028 $0.00495 $0.00504 $0.00768 +4,850%
February, 2028 $0.0057 $0.00497 $0.0033 +5,600%
March, 2028 $0.00635 $0.00564 $0.00501 +6,250%
April, 2028 $0.0048 $0.00537 $0.00426 +4,700%
May, 2028 $0.00646 $0.00595 $0.00526 +6,362%
June, 2028 $0.00667 $0.0067 $0.0063 +6,572%
July, 2028 $0.00597 $0.00597 $0.00624 +5,875%
August, 2028 $0.00552 $0.00552 $0.00569 +5,425%
September, 2028 $0.00472 $0.00477 $0.00524 +4,625%
October, 2028 $0.00394 $0.00404 $0.0044 +3,837%
November, 2028 $0.00329 $0.00339 $0.00375 +3,187%
December, 2028 $0.00254 $0.00254 $0.003 +2,437%

REGEN BIOPHARMA INC Stock (RGBP) Price Forecast for 2029

The 2029 price forecast for REGEN BIOPHARMA INC Stock (RGBP) is $0.00539 on average, with a high prediction of $0.0103 and a low estimate of $0.000475. This represents an +5,287% increase from the previous price of $0.0001.
Month Average Low High Change from today's price
January, 2029 $0.0015 $0.0017 $0.00225 +1,400%
February, 2029 $0.00085 $0.00085 $0.00131 +749.81%
March, 2029 $0.0112 $0.000475 $0.0103 +11,119%
April, 2029 $0.0101 $0.0105 $0.00749 +10,012%
May, 2029 $0.00999 $0.0113 $0.0103 +9,887%
June, 2029 $0.00956 $0.0102 $0.00992 +9,462%
July, 2029 $0.00816 $0.0101 $0.00924 +8,056%
August, 2029 $0.0107 $0.0102 $0.01 +10,631%
September, 2029 $0.0101 $0.0102 $0.0101 +10,006%
October, 2029 $0.0086 $0.0088 $0.00952 +8,500%
November, 2029 $0.00767 $0.00787 $0.00827 +7,575%
December, 2029 $0.00657 $0.00667 $0.00739 +6,469%

REGEN BIOPHARMA INC Stock (RGBP) Price Forecast for 2030

REGEN BIOPHARMA INC Stock (RGBP) is expected to reach an average price of $0.00858 in 2030, with a high forecast of $0.0164 and a low forecast of $0.000762. This signifies an +8,481% surge from the last price of $0.0001.
Month Average Low High Change from today's price
January, 2030 $0.00554 $0.00554 $0.00629 +5,444%
February, 2030 $0.00432 $0.00452 $0.00516 +4,219%
March, 2030 $0.00339 $0.00339 $0.00404 +3,292%
April, 2030 $0.00189 $0.00199 $0.00291 +1,787%
May, 2030 $0.000662 $0.000762 $0.00156 +562.21%
June, 2030 $0.0133 $0.0167 $0.0164 +13,175%
July, 2030 $0.0164 $0.016 $0.014 +16,300%
August, 2030 $0.0163 $0.0158 $0.0155 +16,200%
September, 2030 $0.0151 $0.0147 $0.014 +15,025%
October, 2030 $0.0147 $0.0144 $0.0136 +14,625%
November, 2030 $0.0142 $0.0142 $0.014 +14,085%
December, 2030 $0.0125 $0.0125 $0.0135 +12,450%
Cap:     |  Volume (24h):